Geneva Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Geneva Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$326K	Buy
2016 Q4	–	Sell
2016 Q3	$734K	Sell
2016 Q2	$1.42M	Buy
2016 Q1	$207K	Buy
2015 Q3	–	Sell
2015 Q2	$557K	Sell
2015 Q1	$11.7M	Buy